257 related articles for article (PubMed ID: 28704260)
1. α-Solanine reverses pulmonary vascular remodeling and vascular angiogenesis in experimental pulmonary artery hypertension.
Nie X; Dai Y; Tan J; Chen Y; Qin G; Mao W; Zou J; Chang Y; Wang Q; Chen J
J Hypertens; 2017 Dec; 35(12):2419-2435. PubMed ID: 28704260
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
[TBL] [Abstract][Full Text] [Related]
3. Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH.
Courboulin A; Barrier M; Perreault T; Bonnet P; Tremblay VL; Paulin R; Tremblay E; Lambert C; Jacob MH; Bonnet SN; Provencher S; Bonnet S
Eur Respir J; 2012 Sep; 40(3):618-29. PubMed ID: 22496325
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1 signaling pathway.
Liu P; Gu Y; Luo J; Ye P; Zheng Y; Yu W; Chen S
Exp Cell Res; 2019 Jul; 380(1):36-46. PubMed ID: 30802452
[TBL] [Abstract][Full Text] [Related]
5. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol Protects Against Pulmonary Arterial Hypertension in Rats via Activation of Silent Information Regulator 1.
Yu L; Tu Y; Jia X; Fang K; Liu L; Wan L; Xiang C; Wang Y; Sun X; Liu T; Yu D; Cao W; Song Y; Fan Y
Cell Physiol Biochem; 2017; 42(1):55-67. PubMed ID: 28494457
[TBL] [Abstract][Full Text] [Related]
7. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension.
Wang L; Moonen JR; Cao A; Isobe S; Li CG; Tojais NF; Taylor S; Marciano DP; Chen PI; Gu M; Li D; Harper RL; El-Bizri N; Kim YM; Stankunas K; Rabinovitch M
Circ Res; 2023 Mar; 132(5):545-564. PubMed ID: 36744494
[TBL] [Abstract][Full Text] [Related]
9. Grape seed proanthocyanidin reverses pulmonary vascular remodeling in monocrotaline-induced pulmonary arterial hypertension by down-regulating HSP70.
Chen F; Wang H; Yan J; Lai J; Cai S; Yuan L; Zheng S
Biomed Pharmacother; 2018 May; 101():123-128. PubMed ID: 29482057
[TBL] [Abstract][Full Text] [Related]
10. Nur77 downregulation triggers pulmonary artery smooth muscle cell proliferation and migration in mice with hypoxic pulmonary hypertension via the Axin2-β-catenin signaling pathway.
Nie X; Tan J; Dai Y; Mao W; Chen Y; Qin G; Li G; Shen C; Zhao J; Chen J
Vascul Pharmacol; 2016 Dec; 87():230-241. PubMed ID: 27871853
[TBL] [Abstract][Full Text] [Related]
11. Axis inhibition protein 2 deficiency leads to hypoxic pulmonary hypertension through β-catenin signaling pathway.
Nie X; Qin G; Mao W; Wang W; Chang Y; Wei D; Zhou M; Wu B; Chen J
J Hypertens; 2016 May; 34(5):877-92. PubMed ID: 26882042
[TBL] [Abstract][Full Text] [Related]
12. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J
Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.
Boucherat O; Peterlini T; Bourgeois A; Nadeau V; Breuils-Bonnet S; Boilet-Molez S; Potus F; Meloche J; Chabot S; Lambert C; Tremblay E; Chae YC; Altieri DC; Sutendra G; Michelakis ED; Paulin R; Provencher S; Bonnet S
Am J Respir Crit Care Med; 2018 Jul; 198(1):90-103. PubMed ID: 29394093
[TBL] [Abstract][Full Text] [Related]
15. Dihydroartemisinin Attenuates Pulmonary Hypertension Through Inhibition of Pulmonary Vascular Remodeling in Rats.
Tang M; Wang R; Feng P; Dong Q; Chen W; Zhao Y; Li A; Li H; Chen J; Huang W
J Cardiovasc Pharmacol; 2020 Sep; 76(3):337-348. PubMed ID: 32569012
[TBL] [Abstract][Full Text] [Related]
16. FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension.
Bourgeois A; Lambert C; Habbout K; Ranchoux B; Paquet-Marceau S; Trinh I; Breuils-Bonnet S; Paradis R; Nadeau V; Paulin R; Provencher S; Bonnet S; Boucherat O
J Mol Med (Berl); 2018 Feb; 96(2):223-235. PubMed ID: 29290032
[TBL] [Abstract][Full Text] [Related]
17. Serum-glucocorticoid regulated kinase 1 regulates macrophage recruitment and activation contributing to monocrotaline-induced pulmonary arterial hypertension.
Xi X; Liu S; Shi H; Yang M; Qi Y; Wang J; Du J
Cardiovasc Toxicol; 2014 Dec; 14(4):368-78. PubMed ID: 24825325
[TBL] [Abstract][Full Text] [Related]
18. Role for DNA damage signaling in pulmonary arterial hypertension.
Meloche J; Pflieger A; Vaillancourt M; Paulin R; Potus F; Zervopoulos S; Graydon C; Courboulin A; Breuils-Bonnet S; Tremblay E; Couture C; Michelakis ED; Provencher S; Bonnet S
Circulation; 2014 Feb; 129(7):786-97. PubMed ID: 24270264
[TBL] [Abstract][Full Text] [Related]
19. Maresin 1 intervention reverses experimental pulmonary arterial hypertension in mice.
Li H; Li X; Hao Y; Wu C; Fu Y; Su N; Chen H; Ying B; Wang H; Su L; Cai H; He Q; Cai M; Sun J; Lin J; Scott A; Smith F; Huang X; Jin S
Br J Pharmacol; 2022 Nov; 179(22):5132-5147. PubMed ID: 35764296
[TBL] [Abstract][Full Text] [Related]
20. CTRP9 regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and migration via TGF-β1/ERK1/2 signaling pathway.
Li YX; Run L; Shi T; Zhang YJ
Biochem Biophys Res Commun; 2017 Sep; 490(4):1319-1325. PubMed ID: 28688765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
